Sponsors Speakers Agenda Sponsors

Matthew Skelton, MD

Blue Ridge Cancer Care

Representative David Knight

Georgia House of Representatives
R-Georgia

Dr. Matthew R. Skelton graduated with a bachelor of science from Fordham University in New York, New York.  He received his M.D. from Jefferson Medical College in Philadelphia, Pennsylvania in 2001. He completed his internal medicine residency at the Mayo Clinic in Minnesota and his hematology/oncology fellowship at the University of North Carolina in Chapel Hill, North Carolina.  Dr. Skelton is board certified in oncology, hematology and internal medicine and is a diplomat in American Board of Internal Medicine.  

Dr. Skelton is married with three kids and enjoys hiking and skiing in his free time.  

SESSION
Monday, October 24, 2022 (2:00 – 2:45 PM)
Role: Panelist
Diverse Perspectives on What is High-Quality Cancer Care

Kevin Svobada, CPA, CGMA

Chief Executive Officer
Central Georgia Cancer Care

Representative David Knight

Georgia House of Representatives
R-Georgia

With a strong commitment to helping deliver excellent healthcare, Kevin Svoboda serves as Chief Executive Officer. Kevin is responsible for finance and general management for the center. He has an outstanding record for driving improvements across a broad spectrum of key performance measures in healthcare organizations ensuring we are providing the gold standard for patient care. 

Kevin’s experience shows his commitment to community oncology as he started Onnovation Solutions in 2016, a healthcare organization with finance, accounting, program management, and data analytic services all to help medical practices be stronger. In addition, he has served as senior finance, operations, and general management executive with organizations that include Cancer Clinics of Excellence, Bridgehealth Medical, Provident Adult and Senior Care, and others. 

A native of Wisconsin, Kevin graduated with a Bachelor of Science degree in Accounting and Philosophy with a minor in Economics from Marquette University and is licensed as a Certified Public Accountant by the State of Colorado. 

Married with three children, Kevin enjoys travel, fishing, hiking, and reading history or philosophy. 

SESSION
Monday, October 24, 2022 (2:50 – 3:45 PM)
Role: Panelist
The Oncology Medical Home: A Comprehensive & Accountable Model for Quality Cancer Care

Ray Parzik

Senior Director, Value-Based Contracts
Florida Blue

Representative David Knight

Georgia House of Representatives
R-Georgia

In his 20th year at Florida Blue, Ray Parzik currently serves as Senior Director of Value-Based Contracts and is responsible for contracting and operations for commercial value-based programs that include over 1M members and $6B in annual spend.  Since joining Florida Blue, his previous roles include Director of Network Programs, Business Transformation Consultant, Senior Manager of Alternative Payment as well as various leadership roles within Physician Contracting and Operations.  Ray served on Florida Blue’s Executive Leadership Team for Employee Giving for several years, supporting community resources for those in need such as the United Way of Northeast Florida.  Ray was elected as a member to the collegiate honor societies of Phi Beta Kappa and Golden Key and holds bachelor’s and master’s degrees from Florida State University as well as additional certifications in Program Evaluation, Performance Management, and Human Resource Development.

SESSION
Tuesday, October 25, 2022 (9:00 – 9:50 AM)
Role: Panelist
Insurer Perspectives on Oncology Reform Efforts & New Payment Models

Aaron Lyss, MBA

Senior Director, Payment & Policy Innovation
OneOncology

Representative David Knight

Georgia House of Representatives
R-Georgia

Aaron Lyss is the Senior Director of Payment and Policy Innovation for OneOncology, a national partnership of independent community oncology practices. Aaron has led a wide range of initiatives related to the integration of risk-sharing payment models and quality improvement, including the strategic planning and implementation support for practices’ participation in CMMI’s Oncology Care Model, and the development and ongoing management of similar commercial payer partnerships. He also serves on the board of directors for the Patient Advocate Foundation.

Prior to this role with OneOncology, Aaron was the Director of Strategy and Business Development for Tennessee Oncology, and prior to that served as a healthcare policy specialist for the American Association of Blood Banks (AABB).

Aaron earned his Master of Business Administration at the Vanderbilt University Owen Graduate School of Management, and his Bachelor of Arts degree at Washington University in St. Louis.

SESSION
Tuesday, October 25, 2022 (11:05 – 11:55 AM)
Role: Panelist
Cancer Care Team Perspectives on Oncology Reform Efforts &
New Payment Models

Kent Rogers

Chief Customer Officer
EQRx

Teresa Molina

Program Design Manager,
Specialty Collaborative Care
Cigna

Kent is an accomplished senior executive with more than 30 years of experience in product commercialization, sales and marketing, and supply chain logistics, as well as pricing, reimbursement, market access, and growth strategies across the biotech and pharmaceutical industry. Most recently, he was SVP, Industry Relations at OptumRx, a PBM operating as a United Health Group company, leading the formulary contracting and specialty procurement function. Kent previously held leadership roles at the Blue Fin Group (consulting), Acorda Therapeutics, Schering-Plough, and Merck.

Kent holds a Bachelor of Science in Business Management from Indiana University and an MBA from Emory University’s Goizueta School of Business.

SESSION
Monday, October 24, 2022 (4:50 – 5:45 PM)
Role: Panelist
Can We Have a World Without PBMs? Alternative Solutions & Opportunities

Vinay Mehindru, MD, MBA

Founder, Chief Executive Officer
Exemplary Health

Bryan Loy, MD

Physician Lead, Oncology, Laboratory, & Personalized Medicine
Humana

Dr. Mehindru is an accomplished physician executive with over 25 years of healthcare experience that includes population health, physician performance management and building physician alliances with clinical and financial integration. He is well known for taking vision and transforming it into reality through sound strategy development and execution.

Earlier in his career, Dr. Mehindru served as Chief Medical Officer for Wuesthoff Health System (now under Steward Health Care’s ownership) where he led the licensing of a new Coronary Cath lab with interventional capabilities along with the development of a new surgical program. In 2011, he joined AdventHealth Waterman as Chief Medical Officer where he spearheaded the establishment of a new hospitalist program, and also received recognition for excellence in seven metrics under Partnership for Patients (a CMS sponsored program to reduce harm and improve quality). He was the executive sponsor for QUEST, a national program for improving quality and reducing cost.

His continued success led to Dr. Mehindru’s appointment as the President of AdventHealth Physician Network, Tampa Bay (formerly called Physician Alliance of Florida Hospital) and AdventHealth Physician Network Ocala (formerly called Physician Health Partners at Munroe Regional). As the President of these Clinically Integrated Networks (CINs), and with his focus on population health management, he responsibly managed over 40,000 covered lives made up of; a self-funded employee health plan, a commercial health plan and Medicare beneficiaries. In his journey towards transforming health care from volume-based to value-based, Dr. Mehindru successfully built a network of over 1,000 physicians, established quality benchmarks and metrics, and bent the total healthcare spend cost curve from a historic annual increase of fifteen percent (15%) to just one percent (1%).

In his continued passion to improve outcomes for patients, Dr. Mehindru led the initiatives between the two major health systems in the Tampa Bay, Florida area, consisting of an exclusive health and wellness innovation partner for the first planned “Smart Gigabit Community,” a 160 employee Home Health Care company, and a Joint Venture with the largest local radiology physicians group, including 16 outpatient imaging centers.

Dr. Mehindru served as a member of AdventHealth West Florida Division Strategy and Growth Council that oversees strategic initiatives of this $1.5 billion revenue division. He also served as a judge and a council member for Innovation X, National Council of Presidents. This is an AdventHealth annual premier competition for start-ups and mid-stage innovative companies to present their solutions to top health challenges that align with strategic AdventHealth imperatives.

His participation on AdventHealth boards and committees also included the Population Health Service Organization, the Accountable Care Organization, and the Population Health IT.

Dr. Mehindru completed his internal medicine residency with the Cleveland Clinic Foundation, and emergency medicine residency with the University of Florida, and also received his executive MBA in healthcare management from University of Texas at Dallas.

SESSION
Monday, October 24, 2021 (4:50 – 5:45 PM)
Role: Panelist
Can We Have a World Without PBMs? Alternative Solutions & Opportunities

Dickon Waterfield

Chief Commercial Officer
Employer Direct Healthcare

Robert J. Smith, MBA

Executive Director, Colorado Business Group on Health

Prior to EDH, Dickon was Chief Commercial Officer at WithMe Health, a modern PBM backed by Oak HC/FT. Prior to WithMe, Dickon was the Chief Commercial Officer at Big Health, a digital therapeutics company focused on mental health. Dickon was responsible for the go-to-market strategy, establishing product positioning, pricing and market and channel prioritization. During his tenure, Dickon grew the business from 0 to 2.5mm covered lives. Customers included Citi, Comcast, CVS, Delta, EY, Google, Target, and The Home Depot. To accelerate growth, he launched a first of its kind, strategic partnership with CVS, which became the CVS Point Solution Management platform.

SESSION
Tuesday, October 25, 2022 (10:05 AM – 11:00 AM)
Role: Panelist
Employer Perspectives on Oncology Reform Efforts & New Payment Models

 

Chris Skisak, PhD

Executive Director
Houston Business Coalition on Health

John Reuland

Leader, Access Communication
Johnson & Johnson

Chris Skisak, PhD is the Executive Director of the Houston Business Coalition on Health, a multi-stakeholder but employer-centric 501(c)(3) focused on improving the cost, quality, and consumer experience in healthcare delivery.  Dr. Skisak also serves on the Boards of Directors of the National Alliance of Healthcare Purchasing Coalitions, Texas Business Group on Health, and Texas employers for Affordable Healthcare.  He serves on the leadership councils for Houston Cities Changing Diabetes, Houston Health Equity Collaborative, and Center for Houston’s Future. He had previously worked 25 years with Houston Fortune 50 energy companies in a variety of population health management positions.  He is originally from Chicago.  He received his M.S. and PhD from the University of Texas School of Public Health and has published more than 20 peer-reviewed in scientific journals.

SESSION
Monday, October 24, 2022 (2:00 – 2:45 PM)
Role: Panelist
Diverse Perspectives on What is High-Quality Cancer Care

Bret Jackson

President
Economic Alliance for Michigan

Marcus Garcia

Senior Director Payer & Strategy Relations
Rocky Mountain Cancer Centers

Bret Jackson is the president of the Economic Alliance for Michigan (EAM), a nonprofit comprised of businesses and unions working together for the continued growth of Michigan’s economy, providing health benefits to an estimated 900,000 Michiganders. In his role, Bret oversees all EAM activities and operations including policy development, programming, research, member engagement and events such as the Health Purchaser Forum, EAM Friday Forums, Oncology Symposium, and other various employer/health purchaser roundtables. He also serves as the Policy Chair and Vice Chair of the National Alliance of Healthcare Purchaser Coalitions and is a member of the National Quality Forum Patient Safety Standing Committee.

SESSION
Tuesday, October 25, 2022 (8:10 – 8:55 AM)
Role: Panelist
New Strategies for Insurance Benefit Designs: From the Simple to the Complex

David Cosgrove, MD

Medical Director
Compass Oncology

Patrick Davish

Associate Vice-President, Merck & Co., Inc.

Dr. Cosgrove specializes in general adult oncology with advanced subspecialty expertise in gastrointestinal (GI) cancers. He is a strong advocate for bringing leading edge therapies to his patients through clinical trials. He serves as co-chair on The US Oncology Research Network’s national GI Research Committee and as a principal investigator for many network studies. He was the Director of Research for Compass Oncology until early 2022, when he took on the role of Medical Director for his practice.

He was Physician Champion at Compass Oncology for the Oncology Care Model from 2017-2022 and currently leads Value Based Care initiatives within a robust Quality Program at this site.

Dr. Cosgrove’s approach to patient care is very team oriented. He strives toward open communication by encouraging questions and ongoing follow up from patients and families, and nurturing care team members to bring their contributions to the fore. He is a source of information for his patients and a caring sounding board for emotional support. In his spare time Dr. Cosgrove remains an avid soccer player, and occasional golfer. He enjoys the Oregon outdoors with his wife and two young daughters.

SESSION
Tuesday, October 25, 2022 (11:05 – 11:55 AM)
Role: Panelist
Cancer Care Team Perspectives on Oncology Reform Efforts & New Payment Models

 

Michael Thompson

President, Chief Executive Officer
National Alliance of Healthcare Purchaser Coalitions

Susan Sabo-Wagner, RN, BSN, OCN

Clinical Director, Oncology Consultants

Michael Thompson is the President and CEO of the National Alliance of Healthcare Purchaser Coalitions (National Alliance). The National Alliance is an alliance of approximately 50 healthcare purchaser-led coalitions collectively supporting over 12,000 healthcare purchasers providing health coverage to over 45 million Americans. The National Alliance helps to lead improvements in health, well-being and value for our companies and communities across the country.

Prior to joining the National Alliance, Mike was a Principal at PricewaterhouseCoopers (PwC) for the 20 years. Thompson is a nationally recognized thought leader for business health strategies and health system reform. He has worked with major employers and other stakeholders on sustainable cost reduction, integrated health, wellness and consumerism, retiree health, private health exchanges and health reform. Known for developing and promoting collaborative cross-sector health industry initiatives, Mike participated on the steering board of the World Economic Forum’s “Working towards Wellness” initiative and co-founded the Private Exchange Evaluation Collaborative (PEEC). Prior to joining PwC, Mike served as an executive with diverse roles with Prudential Healthcare for over 17 years.

Mike is a Fellow of the Society of Actuaries, serving on the Health Practice Council, and chairs the Medicare Sub-Committee of the American Academy of Actuaries (AAA). He is also widely recognized as a leading national advocate for mental health and well-being and was Past President of the New York City chapter of the National Alliance for Mental Illness (NAMI). Mike previously was also an active member of the board of the Northeast Business Group on Health for 11 years.

SESSION
Tuesday, October 25, 2022 (10:05 – 11:00 AM)
Role: Panelist
Employer Perspectives on Oncology Reform Efforts & New Payment Models

 

Bill Lacy, MBA

Chief Executive Officer
Association for Corporate Health Risk Management

Amy King

Administrator
Nebraska Hematology-Oncology

Bill Lacy has over 35years experience in executive and financial leadership positions. Currently, Bill serves as the CEO for the Association for Corporate Health Risk Management (ACHRM), a membership-based organization comprised of progressive employers ranging in size up to 50,000 employees and best-in-class vendors (Sponsor Partners) and consultants seeking education, a venue to collaborate, innovative methodologies, disruptive technologies and other resources to more effectively contain their organization’s healthcare costs.

ACHRM has offered 300 virtual and in-person events since its launch in June, 2012 engaging more than 1,000 employers and other professionals. The Association has published several white papers, case studies and launched various pilots to introduce new methodologies to assist employers with their healthcare cost containment strategies. Recently, ACHRM was engaged by both a large mid-western City and mid-Atlantic County to analyze and design a healthcare cost containment plans, with upwards of $150 million dollars in savings.

Prior to ACHRM, Bill was CFO and COO for Business Health Services, a national Corporate Wellness and Behavioral Risk Management provider based in Baltimore, Maryland; and CFO for Planet Fitness PA based in Lafayette Hill, PA. Bill has also held executive positions with the Association for Corporate Wellness (ACW), BB&T (Equity) Bank, Exelon (PECO) Energy, Rainbow Industrial Products, NatWest, and Entre Advisors LLC. Bill is Adjunct Professor, Pfeffer University teaching MBA Finance and currently serves on the University of the Sciences’ Board of Visitors, and previously served on other not-for-profit and for-profit boards. Bill is an Eagle Scout. He earned his MBA (finance and marketing) from Drexel University and BS (math and economics) from Ursinus College.

SESSION
Tuesday, October 25, 2022 (10:05 – 11:00 AM)
Role: Panelist
Employer Perspectives on Oncology Reform Efforts & New Payment Models

 

Melissa Austin

Supervisor Revenue Cycle
Cancer Care Centers of Brevard

Melissa Austin

Supervisor Revenue Cycle
Cancer Care Centers of Brevard

Melissa Austin has more than 20 years of healthcare experience. Her career started with a multi-specialty practice in the early 2000’s where she worked in both the clinical and administrative setting. In 2014 her focus turned to Oncology care. Her passion is Financial Counseling and helping to provide patients with access to affordable, quality healthcare. Melissa has an Associates Degree in Science obtained from Florida Metropolitan University. She lives in Brevard County and enjoys spending her free time with her son.

SESSION
Monday, October 25, 2021 (3:15–3:55 PM)
Role: Panelist
Prior Authorization: Clinical Oversight or Obstacles to Care?

 

Chiara Battelli, MD, PhD

New England Cancer Specialists

Dennis Zoet

Chief Business Development Officer
Cancer & Hematology Centers of Western Michigan, P.C.

Dr. Chiara Battelli was born in Fabriano, Italy. She completed medical school and her Oncology Fellowship in Rome. Eager to learn more about the basic mechanism of cancer development, she moved to the US to work in the laboratory of Dr. Maciag at Maine Medical Center Research Institute.

After completing the PhD program, Dr. Battelli decided to remain in the United States to follow her lifelong dream of practicing medical oncology. She completed the Residency Program in Internal Medicine at Maine Medical Center and then the Fellowship Program in Hematology and Medical Oncology at Harvard Medical School, Beth Israel Deaconess Medical Center, Boston.

She returned to Maine and joined New England Cancer Specialists in September 2013. Dr. Battelli became president and lead physician of the practice in 2018. Her practice focuses on the treatment of breast cancer. She is particularly interested in clinical and translational research, quality improvement, and medical education. In her spare time Dr. Battelli enjoys her family, her friends and her two English Setters. She loves to travel the world, to experience different cultures and their food.

SESSION
Monday, October 24, 2022 (2:50 – 3:45 PM)
Role: Panelist
The Oncology Medical Home: A Comprehensive & Accountable Model for Quality Cancer Care

 

Lynn Kay Winters

Chief Quality & Learning Officer
New York Cancer & Blood Specialists

Lynn Kay Winters

Chief Quality & Learning Officer
New York Cancer & Blood Specialists

Lynn Kay Winters began her career in healthcare as an oncology practice administrator on the east end of Long Island. Acknowledging the need to keep pace with the growing needs of the practice, she completed an MBA in Ambulatory Group Management at the University of St. Thomas in Minneapolis, MN. She achieved a Certified Medical Practice Executive (CMPE) designation from the Medical Group Management Association (MGMA).

After joining New York Cancer & Blood Specialists in 2016, Lynn Kay began project management in National Committee for Quality Assurance to bring practice recognition in the Patient-Centered Speciality Practice (NCQA-PCSP) realm Merit-Based Incentive Payment System (MIPS) management.

Lynn Kay holds the Certified Professional in Healthcare Quality (CPHQ) designation and is an ASQ Certified SixSigma Green Belt.

SESSION
Tuesday, October 26, 2021 (12:30 – 1:10 PM)
Role: Panelist
Measuring the Patient Experience & Outcomes in Cancer Care

Lalan Wilfong, MD

Vice President, Payer Relations & Practice Transformation
The US Oncology Network, McKesson

Lalan Wilfong, MD

Vice President, Payer Relations & Practice Transformation
McKesson Specialty Health

Dr. Wilfong is Vice President of Payer Relations and Practice Transformation at McKesson and a practicing medical oncologist/hematologist, seeing patients at Texas Oncology locations in Dallas. Prior to this role, he served as Vice President of Value Based Care and Quality programs at Texas Oncology and led the launch and implementation of the Oncology Care Model. He also served as medical director of Texas Oncology’s COVID-19 Task Force and was the physician lead for their electronic medical record conversion.

A committed advocate for community oncology, Dr. Wilfong’s focus is transforming cancer care to deliver better outcomes to patients by aligning patient goals and values with treatment options. In his role at McKesson, his priorities are helping define the future of value-based care payment reform, improving patient/physician communication, optimizing actionable analytics, and improving the quality of patient care.

He previously led the Value Based Physician Champion task force for The US Oncology Network and served as chair of the US Oncology Pathways Task Force. He volunteers on the ASCO quality measures task force and the ASCO guidelines committee. He has been honored to receive various teaching and community service awards.

In 2003, Dr. Wilfong completed a fellowship at the University of Texas Southwestern Medical School in hematology and medical oncology. He completed his internship and residency in internal medicine at the University of Texas Southwestern Medical School, Dallas, Texas in 2000. He earned his M.D. from the University of Texas Southwestern Medical School, Dallas, Texas in 1997. He earned a B.S. degree in mathematics at Texas Tech University in Lubbock, Texas in 1993.

SESSION
Monday, October 24, 2022 (12:30 – 1:00 PM)
Role: Panelist
Day One Welcome & Introductions

Tuesday, October 25, 2022 (8:10 – 8:55 AM)
Role: Moderator
New Strategies for Insurance Benefit Designs: From the Simple to the Complex

Tuesday, October 25, 2022 (12:35 – 1:30 PM)
Role: Moderator
Care Delivery & Considerations Outside the Practice: Addressing SDOH & Equity

Tuesday, October 25, 2022 (1:35 – 2:30 PM)
Role: Panelist
Importance of Good Quality Measures in Oncology

Karen van Caulil, PhD

President, Chief Executive Officer
Florida Alliance for Healthcare Value

Stephen Schleicher, MD, MBA

Medical Director, Value Based Care
Tennessee Oncology & OneOncology

President
Tennessee Oncology Practice Society

Karen van Caulil, PhD, joined the Florida Alliance for Healthcare Value in 2011 as the President and CEO. She leads this nationally recognized business coalition on health, overseeing all activities and operations including research projects, educational programs, conferences, and member engagement. She served in leadership positions for the University of Central Florida College and the Health Council of East Central Florida.

Dr. van Caulil represents the Florida Alliance’s mission and work locally, regionally, and nationally, actively serving on numerous boards, advisory committees, and workgroups for organizations such as the National Alliance of Healthcare Purchaser Coalitions, the Center for Workplace Mental Health, Florida’s Agency for Health Care Administration, and the Florida Department of Health.

Dr. van Caulil graduated from Duke University with a BS in Biology and completion of the “Science, Technology and Human Values” degree program. She received a MSPH in Health Policy and Administration from the University of North Carolina at Chapel Hill and an interdisciplinary Doctorate in Public Affairs from the University of Central Florida.

SESSION
Tuesday, October 25, 2022 (8:10 – 8:55 AM)
Role: Panelist
New Strategies for Insurance Benefit Designs: From the Simple to the Complex

 

Alti Rahman, MHA/MBA, CSSBB

Practice Administrator
Oncology Consultants

Alti Rahman, MHA, MBA, CSSBB

Practice Administrator
Oncology Consultants

Alti is the Practice Administrator for Oncology Consultants. He holds a dual Masters degree in Healthcare and Business Administration from the University of Houston and is a Certified Six Sigma Black Belt (CSSBB).

Oncology Consultant’s has 14 Medical Oncology offices. Ancillary services include 2 Radiation Oncology office, 2 Diagnostic Imaging centers, 3 Retail Pharmacy’s, and Clinical Research programs all supported by a central administrative office.

Alti holds additional roles including Board Member of COA (Community Oncology Alliance), Chair of the Health Equity Committee (COA), Member of the Houston Cancer Health Equity Coalition, Treasurer for the National Cancer Care Alliance (NCCA), and President of the Coalition of Hematology and Oncology Practices (CHOP).

SESSION
Tuesday, October 25, 2022 (12:35 – 1:30 PM)
Role: Moderator
Care Delivery & Considerations Outside the Practice: Addressing SDOH & Equity

 

Pete Scruggs

Principal
Golsan Scruggs Insurance & Risk Management
Founder
benefitSmart Cancer Solutions

Debra Patt, MD, PhD, MBA

Vice President
Texas Oncology, US Oncology

Pete Scruggs has provided employee benefit solutions to employers for 30 years as Principal of Golsan Scruggs Insurance & Risk Management and Founder of benefitSMART Cancer Solutions.

benefitSMART Cancer is a nationwide program providing financial hope and social support to families fighting cancer. 

With a mission to make cancer treatment cost free to 100% of the patients insured through self-funded employers, benefitSMART has become a trusted partner to oncology providers, insurance consultants and stop loss carriers.

Pete received the 2017 Innovation Award from the Association for Insurance Leadership for his contributions to the advancement of the industry.

Pete was a contributing author of “Breaking Through The Status Quo: How Innovative Companies are Changing the Benefits Game to help their employees and Boost their Bottom Line.”

SESSION
Tuesday, October 25, 2022 (8:10 – 8:55 AM)
Role: Panelist
New Strategies for Insurance Benefit Designs: From the Simple to the Complex

 

John Sargent, MD, MSt

Founding Partner
BroadReach Group

Kathy Oubre, MS

Chief Operating Officer
Pontchartrain Cancer Center

Dr. John Sargent is a social entrepreneur focused on applying 4th Industrial Revolution technologies to radically improve healthcare delivery and catalyze broader development sector outcomes.

John co-founded BroadReach Group in 2003 with the mission to improve healthcare access and outcomes for underserved populations.   BroadReach has worked in over 25 countries in Africa, Asia, Europe and the Americas.  He has been recognized by the World Economic Forum as one of the Social Entrepreneurs of the Year in 2015 and by Frost & Sullivan with the Visionary Leadership Award in Healthcare.

Prior to the BroadReach Group, John was a Senior Director at the Advisory Board Company specializing in strategic and clinical operations projects for US health systems.  He has served on the Board of Directors of the Fulbright Association. John earned an undergraduate degree from Dartmouth College, a master’s degree from Oxford University as a Fulbright Scholar and an MD from Harvard Medical School.

SESSION
Tuesday, October 25, 2022 (12:35 – 1:30 PM)
Role: Panelist
Care Delivery & Considerations Outside the Practice: Addressing SDOH & Equity

Ted Okon, MBA

Executive Director
Community Oncology Alliance (COA)

Ted Okon, MBA

Executive Director
Community Oncology Alliance (COA)

Ted Okon is a nationally recognized expert on the policy and politics of cancer care. He is quoted extensively in the press, including guest appearances on TV and radio news shows. Ted has testified before Congress on cancer issues and is frequently on Capitol Hill discussing the nation’s cancer care delivery system. Ted’s target areas of expertise include the cost of cancer treatment, health care reform, Medicare reimbursement, pharmacy benefit managers (PBMs), drug shortages, and the changing landscape of cancer care delivery in the United States.

Ted has dedicated his career to healthcare business and policy. He has worked for several pharmaceutical companies including Merck and Warner-Lambert, now part of Pfizer, and IMS Health. He co-founded and took public the health care information business Medical Marketing Group. He also founded two oncology companies (an oncology clinical research network and an information network) and has traveled extensively to China, India, Singapore, the U.K., and the Middle East, analyzing and discussing cancer care delivery.

As executive director of the Community Oncology Alliance (COA), Ted oversees the strategic direction of this non-profit organization dedicated to patients and providers in the community cancer care setting, under the direction of a dedicated board of oncologists and practice administrators. Ted also travels the country speaking to state oncology societies, professional organizations, and companies about the challenges facing the nation’s cancer care delivery system. He has authored numerous articles and studies relating to cancer care policy and politics, reimbursement, and clinical issues.

Ted holds a BS degree from Fairfield University and an MBA from the Carnegie-Mellon University Tepper School of Business. His wife, Susan, practiced as a certified oncology nurse.

SESSIONS
Monday, October 24, 2022 (7:30 – 9:00 PM)
Role: Moderator
Dinner Discussion: Value-Based Care in Action

Ed Licitra, MD, PhD

Chairman, Chief Executive Officer
Astera Cancer Care

Representative David Knight

Georgia House of Representatives
R-Georgia

Edward J. Licitra, MD, PhD received his PhD in Biochemistry from the Massachusetts Institute of Technology, where he was a National Cancer Institute Predoctoral Fellow. He is a graduate of the University of Medicine & Dentistry of New Jersey, Robert Wood Johnson Medical School and also served his internship and residency there. Dr. Licitra was the recipient of the Robert Wood Johnson Medical School Research Award and was designated as the Medical School’s Department of Internal Medicine Outstanding Resident. He then completed a fellowship in Medical Oncology at the Cancer Institute of New Jersey and was an attending physician at Memorial Sloan Kettering Cancer Center. He is certified by the American Board of Internal Medicine in Medical Oncology. Dr. Licitra has been chosen as a Top Doctor in Oncology & Hematology by New Jersey Monthly magazine. He will serve as Chairman and Chief Executive Officer of Astera Health Partners. He is on the Board of Directors of OneOncology, The Community Oncology Alliance (COA) and the ION Advisory Board.

SESSION
Monday, October 24, 2022 (7:30 – 9:00 PM)
Role: Panelist
Dinner Discussion: Value-Based Care in Action

Sibel Blau, MD

President & Chief Executive Officer
Quality Cancer Care (QCCA)

Medical Director, Oncology Division
Northwest Medical Specialties, PLLC

Glen Balasky

Executive Director
Rocky Mountain Cancer Centers

Dr. Sibel Blau is a Hematologist and Oncologist with special interest and expertise in breast cancer, multiple myeloma and stem cell transplant.

She is the Medical Director at Northwest Medical Specialties, PLLC, where she also runs the clinical research and Precision Medicine program. 

She is one of the founding members and the President/CEO of the Quality Cancer Care Alliance Network (QCCA) that is a national organization with a focus of value-based care, education, and research as well as Exigent Research, an innovative research network of independent practices throughout the US to provide high quality, accelerated and accessible research to the communities where patients are treated.  She is a board member and past President of Washington State Medical Oncology Society (WSMOS). She is involved in multiple committees at national organizations like ASCO, COA, ACCC.

She is also a member of All4cure, which is a transparent platform for discussion between experts in myeloma, researchers, scientists and patients. 

She is the founder and president of the Journey Fund which is a community-based, not-for-profit organization committed to cancer patients facing barriers that affect their treatment with donations and community resources that make it possible for us to assist cancer patients facing social, financial, or emotional obstacles, toward a courageous journey, with dignity.

SESSION
Monday, October 24, 2022 (1:00 – 1:55 PM)
Role: Panelist
Practice Perspectives on the EOM: Why or Why Not Participate?

 

Jay Scott

Director, Managed Care
Minnesota Oncology

Elizabeth Mitchell

President, Chief Executive Officer
Purchaser Business Group on Health (PBGH)

Jay has worked in health care in the Twin Cities for 24+ years.  He has held roles in health systems, independent practices and health plans working in finance, quality, performance improvement, payer and provider relations.  In nearly every role for the last decade, he worked on innovation and value based care initiatives.  With Minnesota Oncology, he is the Director of Managed Care where he focuses on value based care, payer relations and quality improvement.

SESSIONS
Monday, October 24, 2022 (7:30 – 9:00 PM)
Role: Panelist
Dinner Discussion: Value-Based Care in Action

Barbara L. McAneny, MD, FASCO, MACP

Chief Executive Officer
New Mexico Cancer Center, Ltd.

Barbara L. McAneny, MD

Chief Executive Officer
New Mexico Oncology Hematology Consultants, Ltd.

Barbara L. McAneny, MD, a board-certified medical oncologist/hematologist from Albuquerque, N.M., became the 173rd president of the American Medical Association in June 2018. She has been a member of the AMA Board of Trustees between June 2010 and June 2020, serving as its chair in 2015–2016. Dr. McAneny is a fellow and former member of the board of directors of the American Society of Clinical Oncology (ASCO), a master of the American College of Physicians, and a past president of the New Mexico Medical Society (NMMS), the Greater Albuquerque Medical Association and the New Mexico chapter of the American College of Physicians. In addition, she has served as a member of the Community Oncology Alliance Board of Trustees and on the board of directors of the Cancer Center Business Summit. She became the delegate to the AMA from ASCO in 2002 and was elected to the AMA Council on Medical Service in 2003, serving as its chair in 2009–2010. Dr. McAneny is one of the founders and current chair of the board of the National Cancer Care Alliance, a group of independent practices collaborating to use innovation to deliver high-quality, high-value cancer care and to develop new alternative payment models based on sound data-driven principles. Prior to this, she was a founding member of Oncology Circle, a group of oncology practices using data to promote best practices. Dr. McAneny’s interest in using data to improve practice sustainability began when she was appointed to the Centers for Medicare & Medicaid Service’s Practicing Physicians Advisory Council, where she served from 2002 to 2006. In 2012 Dr. McAneny received a $19.8 million grant from the Centers for Medicare & Medicaid Innovation to demonstrate how oncology practices could use triage pathways to dramatically lower costs while improving outcomes. This award, named COME HOME (for Community Oncology Medical Home), later was incorporated into Medicare’s Oncology Care Model. Dr. McAneny also co- founded New Mexico Oncology Hematology Consultants Ltd. in 1987 with Clark Haskins, MD. A managing partner since 1999, she built New Mexico Cancer Center as the first physician-owned multi-disciplinary cancer center in the state with clinics in Albuquerque and Gallup. She also founded the New Mexico Cancer Center Foundation, which provides grants to help patients with nonmedical expenses. Dr. McAneny graduated magna cum laude from the University of Minnesota in 1973 and with honors from the University of Iowa College of Medicine in 1977. She completed her residency in internal medicine at the University of Iowa in 1980 and her fellowship in hematology/oncology at the University of New Mexico in 1983. She is married to Steven Kanig, MD.

SESSION
Monday, October 24, 2021 (1:00– 1:55 PM)
Role: Panelist
Practice Perspectives on the EOM: Why or Why Not Participate?

 

Stacie Mason

Provider Partner Principal, Provider Relations
BlueCross BlueShield of Minnesota

Jonathan E. Levitt, Esq.

Founding Partner
Frier Levitt, LLC

Stacie Mason currently serves as the Principal Provider Partner for key strategic provider groups for Blue Cross Blue Shield of Minnesota (BCBSMN).

Stacie has more than 25 years of experience in managed health care in Provider Relations, Medicare Product Management and Project Management with Aetna, CIGNA, HealthPartners and Medica Health Plans in both Ohio and Minnesota. 

Additionally, Stacie served as an adjunct instructor at Cardinal Stritch University for 15 years teaching communication.

She received her BA from Baldwin-Wallace College and MA from Cleveland State University and currently resides in Mound, MN.  

SESSION
Tuesday, October 25, 2022 (9:00 – 9:50 AM)
Role: Panelist
Insurer Perspectives on Oncology Reform Efforts & New Payment Models

 

Scott Kruger, MD, FACP

Medical Director
Virginia Oncology Associates

Gary Kay, MD

Medical Oncologist
Northwest Oncology & Hematology, S.C.

Dr. Scott Kruger is an Alpha Omega Alpha graduate of LaSalle University and Jefferson Medical School in Philadelphia, Pennsylvania. He then went on to serve in the United States Army where he completed his internship and Internal Medicine residency at Walter Reed Army Medical Center in Washington D.C. He completed his fellowship training in Hematology-Oncology at Letterman Army Medical Center and a visiting fellowship in bone marrow transplant at the Hutchinson Cancer Research Center.

Dr. Kruger is board certified in Internal Medicine, Hematology and Oncology. He has served on numerous committees in both the U.S. and Europe and has been awarded both military and civilian honors which include: The Meritorious Service Medal (twice), Army Achievement Medal, the Commander’s Award for Excellence, and the National Red Cross Volunteer Award.

Dr. Kruger is Medical Director at Virginia Oncology Associates. He has also been involved in clinical trials and research and has developed numerous presentations. Dr. Kruger is an active member on the board of the US Oncology P&T committee where he serves as the chairman of the pharmacy subcommittee, as well as the chairman for the Institutional Review Board for Eastern Virginia Medical School.

SESSION
Tuesday, October 25, 2022 (11:05 – 11:55 AM)
Role: Panelist
Cancer Care Team Perspectives on Oncology Reform Efforts & New Payment Models

Rajini Katipamula-Malisetti, MD

Minnesota Oncology

Andrew Hertler, MD, FACP

Chief Medical Officer
New Century Health

Dr. Rajini Malisetti, referred by her peers as Dr. K, practices medical oncology and Hematology at Coon rapids, Minnesota. She has done her medical school in India and subsequently done her residency at St. Vincent Hospital in Worcester, Massachusetts. She has completed her fellowship in Oncology and Hematology at Mayo Clinic and has been with Minnesota Oncology for the last 14 years.

Dr. Katipamula-Malisetti has presented at ASCO and the Mayo Clinic on various oncologic topics. She is also co-author of several research papers in such publications as the Journal of Clinical Oncology and Clinical Medicine. She is currently the Quality Medical Director for Minnesota Oncology and has been passionate about being engaged in this space.

Dr. Malisetti is especially interested in bringing clinical transformation by improving communication between payors and practices that would enhance care and bring value for oncology patients.

She has three daughters, one of them in college and in her free time, she enjoys reading and skiing. She loves to travel and plans to do more of that as time permits.

SESSION
Monday, October 24, 2022 (7:30 – 9:00 PM)
Role: Panelist
Dinner Discussion: Value-Based Care in Action

 

Stephen Grubbs, MD, FASCO

Vice President, Care Delivery
American Society of Clinical Oncology (ASCO)

Stephen Grubbs, MD, FASCO

Vice President, Care Delivery
American Society of Clinical Oncology (ASCO)

Dr. Grubbs joined the American Society of Clinical Oncology (ASCO) in July 2015 as Vice President of the Care Delivery Department after 31 years as a practicing medical oncologist in Newark, Delaware at the Helen F. Graham Cancer Center. He served as managing partner of his independent medical practice, Medical Oncology Hematology Consultants, PA.

The ASCO Care Delivery department supports practicing oncologists both domestically and internationally through ASCO quality programs, practice business intelligence and support, payment reform and value-based care delivery design, practice education, and support of ASCO advocacy. 

He is a chemical engineering graduate of Purdue University and graduate of the Thomas Jefferson University Medical School. Medical postgraduate training in Internal Medicine was completed at the Medical Center of Delaware and Hematology and Oncology at the Dartmouth Hitchcock Medical Center. 

He served as the Principal Investigator of the Delaware Christiana Care NCORP and Board member of the NCI sponsored Alliance cooperative research group. He remains a member for the Alliance Foundation Board and Executive Committee. He is a member of the state of Delaware Cancer Consortium Council and the Early Detection and Prevention Committee.  He is a past member of the ASCO Board of Directors as well as the Ethics, Finance, Research, and Government Relations Committees and past president of the Medical Society of Delaware.

Dr. Grubbs has served as a member of the National Cancer Institute Clinical Trials Advisory Committee, co-chair of the Clinical Trials Subcommittee of the NCI Community Cancer Centers Program (NCCCP), and the Institute of Medicine Committee on Cancer Clinical Trials and the NCI Cooperative Group Program.

He has been an active community based clinical trial investigator with the NCI sponsored CALGB, ECOG, NSABP, and Alliance Cooperative Groups since 1984 and is the recipient of the 2007 Association of Community Cancer Centers David King Community Clinical Scientist Award. 

SESSION
Monday, October 24, 2022 (2:50 – 3:45 PM)
Role: Panelist
The Oncology Medical Home: A Comprehensive & Accountable Model for Quality Cancer Care

 

Bo Gamble

Director of Quality & Value
Community Oncology Alliance (COA)

Bo Gamble

Director of Strategic Practice Initiatives
Community Oncology Alliance (COA)

In his current position with COA, Bo Gamble has been responsible for the development of the principles and metrics associated with the Oncology Medical Home (OMH) program. Working with COA members and payers, the OMH program was developed in 2012 and participating practices began using this practice model immediately.

Robert “Bo” Gamble joined the Community Oncology Alliance (COA) in May 2011 as the Director of Quality and Value. Mr. Gamble brings a diverse range of cancer practice expertise at the national and local levels. His extensive experience includes 13 years’ experience as administrator at a multi-physician, multi-location oncology practice, and medical IT consulting to Big Eight accounting firms. Prior to that, he served in various health care capacities as an independent consultant for hospital patient accounting and IT implementation projects, National Director of Client Support for a health care software company, and business office manager for a 300+ bed hospital. He got his beginning as a hospital orderly during his college years.

Bo has also served as the President and Legislative Chairperson for the North Carolina Oncology Practice Management Society, a member of the COA Board of Directors, and the co-chair of the national COA Administrators’ Network.

Bo holds a Bachelor of Science in Business Administration with a specialization in Health Care Management from Appalachian State University.

SESSIONS
Monday, October 24, 2022 (12:30 – 1:00 PM)
Role: Panelist
Day One Welcome & Introductions

Monday, October 24, 2022 (2:00 – 2:45 PM)
Role: Moderator
Diverse Perspectives on What is High-Quality Cancer Care

Monday, October 24, 2022 (2:50 – 3:45 PM)
Role: Panelist
Diverse Perspectives on What is High-Quality Cancer Care

Tuesday, October 25, 2022 (8:00 – 8:10 AM)
Role: Speaker
Day Two Opening Remarks

Tuesday, October 25, 2022 (10:05 – 11:00 AM)
Role: Moderator
Employer Perspectives on Oncology Reform Efforts & New Payment Models

Park Ginder, PhD

Superintendent
Southwest Allen County Schools 
Cancer Survivor

Aharon “Ronny” Gal, PhD

Founder
Moto Bioadvisors

Park Ginder never saw himself as a Superintendent of schools. He graduated from Ball State University in 1986 with a BS in Art Education, received his master’s from IPFW in 1994, got his admin certification in 2002, an Ed.S. from IU Bloomington in 2007, before lastly receiving a Ph.D. at Purdue University in 2018. 

He has been in education for 37 years, having taught art, computer graphics, and photography, and, also, coached high school baseball. He is currently in his second year as Superintendent of Southwest Allen County Schools in Fort Wayne, Indiana.

Park has been living with CLL for five years. He is under the care of Dr. Shalini Chitneni, Dr. Ahad Sadiq, and Dr. Sunil Babu at Fort Wayne Medical Oncology and Hematology.

He has been married to his best friend, Gabrielle, for 34 years, and they have four children, who are all married, with seven grandkids.

SESSION
Monday, October 24, 2022 (2:00 – 2:45 PM)
Role: Panelist
Diverse Perspectives on What is High-Quality Cancer Care

 

René Frick

Senior Director, Network Innovation & Partnerships
BlueCross BlueShield of South Carolina

Nicolas Ferreyros

Director of Communications
Community Oncology Alliance (COA)

As senior director of Provider Network Innovations & Partnerships, Rene is responsible for the development and implementation of alternative and performance-based contract models for their participating providers. This includes several value-based provider contracting initiatives such as accountable care organizations, pay-for-performance agreements, specialty care programs and other payment and system innovations. Most recently, Rene is the lead on developing several value-based networks throughout the state for accountable care organization arrangements.

Rene has worked with BlueCross® BlueShield® of South Carolina for 26 years. Prior to 2011, she was senior director for Provider Network Services. That area was responsible for network development and education of all the physician practices for BlueChoice® HealthPlan of South Carolina, a subsidiary of BlueCross BlueShield of South Carolina. Both BlueCross and BlueChoice® are independent licensees of the Blue Cross and Blue Shield Association.

Before joining BlueCross, Rene was marketing manager for Aiken Regional Medical Centers. Her responsibilities included market research, strategic planning and physician recruitment for the community hospital.

SESSION
Tuesday, October 25, 2022 (9:00 – 9:50 AM)
Role: Panelist
Insurer Perspectives on Oncology Reform Efforts & New Payment Models

Susan Escudier, MD, FACP

Vice President, Value-Based Care & Quality Programs
Texas Oncology

A. Mark Fendrick, MD

Director, Center for Value-Based Insurance Design
University of Michigan

Susan Escudier, M.D., FACP, serves as vice president, value based care and quality programs for Texas Oncology. She also serves as regional medical director for Texas Oncology’s Gulf Coast region.  Dr. Escudier joined Texas Oncology in 1994 and practices at Texas Oncology–Houston Medical Center. Since she joined Texas Oncology, Dr. Escudier has served on the board of directors and numerous committees, including the practice’s medical oncology quality committee.  She is a clinical associate professor of medicine at Baylor College of Medicine in Houston.

SESSION
Monday, October 24, 2022 (1:00 – 1:55 PM)
Role: Panelist
Practice Perspectives on the EOM: Why or Why Not Participate?

 

Stephanie Broussard, MSSW, LCSW-S, APHSW-C

Director of Palliative Care & Social Work
Texas Oncology

Rachel DuPré Brodie

Senior Director, Measurement & Accountability
Purchaser Business Group on Health (PBGH)

Stephanie Broadnax Broussard is a board-approved LCSW Supervisor (LCSW-S), Certified Advanced Palliative and Hospice Social Worker(APHSW-C), and a Certified Advanced Care Planning Facilitator and Trainer. A proud Louisiana native, she graduated from Louisiana Tech University. She continued to the University of Texas at Arlington, where she received her Master’s degree and is currently pursuing her Doctoral degree at the University of Kentucky. Stephanie is the Director of Palliative Care and Social Work at Texas Oncology and a therapist in private practice.

Stephanie enjoys educating the community and other clinicians on the importance of end of life care, communication, understanding the needs of the communities we serve, social justice, and  health equity.  

 As a motivational speaker and educator, Stephanie engages and challenges her audiences with her witty yet straightforward approach. The versatility in her messages has afforded her opportunities to grace national and local platforms. Stephanie also enjoys sharing these messages and moments on her podcast, “It Comes with Living.”

Stephanie serves her community in many capacities. Stephanie currently serves on the Board of Directors for community organizations; Women In Power Empowering and  Care and Prepare ( Formerly Coalition For Quality End of Life Care). Stephanie is also a proud member of Alpha Kappa Alpha Sorority, Inc. 

Although proud of her professional accolades, Stephanie holds being the Wife to Cory and the mother of her two boys, Cory and Corben, as her most significant honor. A self-declared “foodie,” Stephanie believes she has a chef’s palette. Still, she is keenly aware that has not translated into an ability to make great food.

SESSION
Tuesday, October 25, 2022 (12:35 – 1:30 PM)
Role: Panelist
Care Delivery & Considerations Outside the Practice: Addressing SDOH & Equity

 

Michael Diaz, MD

President & Managing Physician
Florida Cancer Specialists & Research Institute

Michael Diaz, MD

Director of Patient Advocacy & Assistant Managing Physician
Florida Cancer Specialists & Research Institute

Dr. Michael Diaz joined Florida Cancer Specialists & Research Institute (FCS) in 2011 and is currently President and Managing Physician for the statewide practice. He serves on the FCS Executive Board and as Director of Patient Advocacy for the practice.

As a hematologist and oncologist, Dr. Diaz has a deep interest in treating breast, lung, colorectal, gastrointestinal, genitourinary, skin and blood and bone marrow malignancies. In addition to his medical practice, Dr. Diaz provides leadership for a number of organizations, including serving as a current member and Immediate Past Chair of the Florida Cancer Specialists Foundation Board of Directors, which offers non-medical financial assistance to qualified cancer patients in Florida.

He serves as the Director of Patient Advocacy and Federal Legislative Committee Chair for the Florida Society of Clinical Oncology (FLASCO), as well as being a Past President. Dr. Diaz advocates nationally for cancer patients and practices by serving as the Immediate Past President of Community Oncology Alliance (COA) as well as the Co-Chair for the practices reform workgroup, which develops quality and value based alternative payments models.

He advocates for Florida Medicaid patients by serving on the Florida Medicaid Pharmaceutical and Therapeutics Committee to ensure access to state of the art, quality-based care, and advises the Florida Governor’s office and State Legislature by serving on the Florida Cancer Control & Research Advisory Council. Dr. Diaz is on the Board of Directors for the National Cancer Treatment Alliance, which works with regional/national employers as well as their health care coalitions to improve the understanding of quality and value-based cancer care and develop collaborative programs related to cancer care. Dr. Diaz also serves on the FCS Finance Committee.

As a part of his philanthropic commitment, Dr. Diaz is dedicated to providing medical care to populations who are underserved and has participated in numerous medical missions to Kingston, Jamaica.

SESSION
Monday, October 24, 2022 (12:30 – 1:00 PM)
Role: Panelist
Day One Welcome & Introductions

Monday, October 24, 2022 (1:00 – 1:55 PM)
Role: Moderator
Practice Perspectives on the EOM: Why or Why Not Participate?

Monday, October 24, 2022 (4:50 – 5:45 PM)
Role: Moderator
Can We Have a World Without PBMs? Alternative Solutions & Opportunities

Tuesday, October 25, 2022 (9:00 – 9:55 AM)
Role: Moderator
Insurer Perspectives on Oncology Reform Efforts & New Payment Models

Tuesday, October 25, 2022 (11:05 – 11:55 AM)
Role: Moderator
Cancer Care Team Perspectives on Oncology Reform Efforts & New Payment Models

Tuesday, October 25, 2022 (1:35 – 2:30 PM)
Role: Panelist
Importance of Good Quality Measures in Oncology

Brian Corvino, MBA

Managing Director
Life Sciences & Health Care Practice, Deloitte Consulting, LLP

E. Randolph “Randy” Broun, MD

Physician Partner, Bone & Marrow Transplant Specialist
OHC

Brian brings almost 20 years of experience serving life sciences and healthcare clients in the area of biopharmaceutical value, access and pricing.  He has dedicated his career to advancing new perspectives on the growing challenge of sustainable pricing, affordability, access, and value for increasingly transformative drug therapies in oncology, cell & gene therapy and rare diseases.

Brian leads Deloitte’s efforts in the area of biopharmaceutical Value and Access strategy formulation.  In addition, Brian co-leads Deloitte’s Center for Oncology Transformation, which is a cross functional industry group dedicated to enabling advancement of innovation within cancer care.

Brian has a passion for leadership development, coaching and mentoring and has been recognized by PharmaVoice as a Top 100 “Most Inspiring Leader” in the Life Sciences Industry.  He continues to actively advance thinking around the balance of sustainable access to innovation, at several leading global universities.

Brian received his Bachelors degree from Moravian University and his MBA from the Wharton Business School at the University of Pennsylvania.

SESSION
Monday, October 24, 2022 (3:50 – 4:45 PM)
Role: Speaker
Demystifying Drug Prices: Better Understanding the Elephant in the Shadows

 

Greg Baker, RPh

Founder, Chief Executive Officer
EmsanaRx

Robert Baird, Jr. RN, MSA

President
National Cancer Treatment Alliance (NCTA)
Cancer Pharmacy Network (CPN)

As CEO, Greg Baker strategically develops EmsanaRx’s mission for drive better health, predictable costs and a partnership that puts employers in control. Greg has decades of experience in pharmacy as a Pharmacist, businessman, and entrepreneur. He leads EmsanaRx in three core areas: 1. Cost Transparency, 2. Data Control and 3. Patient Health improvement. He is passionate about creating a clinically-focused versus a financially-focused PBM.

At EmsanaRx, Greg leverages his prior experience working as the pharmacy lead for Premise Health, during which time he maintained the highest levels of operational efficiency, clinical excellence and customer service to provide value within the greater pharmacy healthcare ecosystem. Drawing from this experience, as well as time spent as Pharmacy Supervisor for Walgreens and Senior Pharmacy Consultant for Blue & Co., Greg listens to scores of employers across all industries to customize the highest quality clinical care solutions with the lowest costs for EmsanaRx customers. While in a previous role, Greg led a pharmacy organization that won the 2018 PBMI award for innovation and the 2019 APhA Pinnacle Award. He was also the first community pharmacist appointed by the HHS Secretary to the National Advisory Council for the Agency of Healthcare Research and Quality, where he further advanced the role of pharmacy to improve public health outcomes.

Greg Baker lives by the motto, “By employers, For employers,” in order to make EmsanaRx a nimble company in a large industry determined to do what is right for employers and the millions who work for them.

SESSION
Monday, October 24, 2022 (4:50 – 5:45 PM)
Role: Panelist
Can We Have a World Without PBMs? Alternative Solutions & Opportunities